Octanate Lv (Human Coagulation Factor Viii)

Human Coagulation Factor VIII, the active ingredient in Octanate Lv, is a blood coagulation factor presented as an intravenous solution for intravenous use. It replaces deficient clotting factor VIII in patients with hemophilia A, helping to control bleeding episodes. GNH USA supplies Octanate Lv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octanate Lv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Octanate Lv is used in the management of bleeding disorders that involve the intrinsic coagulation pathway, particularly hemophilia A. - Hemophilia A (severe): Provides factor VIII replacement to prevent or control spontaneous bleeding episodes. - Hemophilia A (moderate): Raises factor VIII activity to achieve hemostasis during minor surgical procedures. - Hemophilia A (mild) :           y